InvestorsHub Logo
Followers 12
Posts 562
Boards Moderated 0
Alias Born 03/08/2009

Re: None

Saturday, 11/28/2009 1:47:35 PM

Saturday, November 28, 2009 1:47:35 PM

Post# of 640835
5 BAGGER BELOW

Full DD. Feb 11th 2010 is the new FDA date. In July of 2009 FDA gave them a complete response letter saying there were deficiencies at the API supplier's manufacturing facility. The letter did not raise any efficacy or safety issues. In October 2009 DDSS received a letter from the facility stating that all deficiencies had been addressed and had been CLASSIFIED AS ACCEPTABLE BY THE FDA. Here is the link for all the information above. Looks and sounds like FDA approval is all but guranteed in Feb 2010.

http://finance.yahoo.com/news/Labopharm-announces-that-its-prnews-1174529232.html?x=0&.v=57

I say %600 based on projected sales of Trazodone. Trazodone is an antidepressant and that is a BIG market. Based on projected revenues from Trazodone $8-$10 is a very reasonable target here. Here is the link showing sales projections.

http://www.newbiomedicine.com/Revere/UploadFiles/file/DDSS%20Trazodone%20Contramid%20FDA%20Approval.pdf


In July of this year DDSS ran up to 2.70 just before the FDA decision date. So for those not wanting to hold through the decision, you could still make a good gain here. Good luck Lionites.

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.